Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1048 | 967 | 1048 | 1000 | 1174 | 1952 |
Fund Return | 4.8% | -3.25% | 4.8% | -0.01% | 3.27% | 6.92% |
Place in category | 263 | 300 | 263 | 191 | 128 | 42 |
% in Category | 74 | 81 | 74 | 60 | 44 | 17 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FC Responsible Global Equity 1 Acc | 1.3B | 13.07 | 1.31 | 10.91 | ||
FC Responsible Global Equity 1 Inc | 1.3B | 12.89 | 1.11 | 10.76 | ||
FC Responsible Global Equity 2 Acc | 1.3B | 13.95 | 2.10 | 11.83 | ||
FC Responsible Global Equity 4 Inc | 1.3B | 14.76 | 2.83 | 12.59 | ||
FC Responsible Global Equity Fund 2 | 1.37B | 13.98 | 2.11 | 11.82 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artemis UK Select Fund G Inc GBP | 3.56B | 25.65 | 10.73 | - | ||
Artemis UK Select Fund R Acc | 3.56B | 24.36 | 9.61 | 8.79 | ||
Artemis UK Select Fund I Acc | 1.86B | 25.30 | 10.43 | 9.63 | ||
Artemis UK Select Fund I Inc GBP | 3.56B | 25.31 | 10.43 | 9.44 | ||
Fidelity Special Situations | 3.2B | 15.54 | 6.38 | 6.87 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 6.31 | 11,050.0 | +0.04% | |
Unilever | GB00B10RZP78 | 4.97 | 53.96 | -0.92% | |
Relx | GB00B2B0DG97 | 3.39 | 3,928.00 | -1.31% | |
National Grid | GB00BDR05C01 | 3.10 | 955.00 | -1.53% | |
Experian | GB00B19NLV48 | 3.09 | 3,787.0 | -0.19% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review